Initial investigation of acoustic droplet vaporization for occlusion in canine kidney.
Acoustic droplet vaporization (ADV) shows promise for spatially and temporally targeted tissue occlusion. In this study, substantial tissue occlusion was achieved in operatively exposed and transcutaneous canine kidneys by generating ADV gas bubbles in the renal arteries or segmental arteries. Fifteen canines were anesthetized, among which 10 underwent laparotomy to externalize the left kidney and five were undisturbed for transcutaneous ADV. The microbubbles were generated by phase conversion of perfluoropentane droplets encapsulated in albumin or lipid shells in the blood. A 3.5-MHz single-element therapy transducer was aligned with an imaging array in a water tank with direct access to the renal artery or a segmental artery. In vivo color flow and spectral Doppler imaging were used to identify the target arteries. Tone bursts of 1 kHz pulse repetition frequency with 0.25% duty cycle vaporized the droplets during bolus passage. Both intracardiac (IC) and intravenous (IV) injections repeatedly produced ADV in chosen arteries in externalized kidneys, as seen by B-mode imaging. Concurrent with this in two cases was the detection by pulse-wave Doppler of blood flow reversal, along with a narrowing of the waveform. Localized cortex occlusion was achieved with 87% regional flow reduction in one case using IC injections. Vaporization from IV injections resulted in a substantial echogenicity increase with an average half-life of 8 min per droplet dose. Gas bubbles sufficient to produce some shadowing were generated by transcutaneous vaporization of intrarenal artery or IV-administered droplets, with a tissue path up to 5.5 cm.
Zhang
M
M
Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48109-5667, USA. maggiez@umich.edu
Fabiilli
M L
ML
Haworth
K J
KJ
Fowlkes
J B
JB
Kripfgans
O D
OD
Roberts
W W
WW
Ives
K A
KA
Carson
P L
PL
D000162:Acoustics; D000818:Animals; D004285:Dogs; D004621:Embolization, Therapeutic / Q000379:methods*; D005240:Feasibility Studies; D045423:Microbubbles; D012077:Renal Artery / Q000000981:diagnostic imaging*; D012079:Renal Circulation; D013010:Sonication / Q000379:methods; D014465:Ultrasonics / Q000379:methods*; D018608:Ultrasonography, Doppler / Q000379:methods; D018615:Ultrasonography, Doppler, Color / Q000379:methods; D014835:Volatilization
Cancer Imaging. 2004 Sep 17;4(2):133-41
18250022
Radiology. 2005 May;235(2):659-67
15858105
J Acoust Soc Am. 2006 Mar;119(3):1432-40
16583887
IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Jul;52(7):1101-10
16212249
J Control Release. 2009 Sep 15;138(3):268-76
19477208
BJU Int. 2003 Aug;92(3):240-4
12887475
IEEE Trans Ultrason Ferroelectr Freq Control. 2002 Jun;49(6):726-38
12075966
Eur J Pharm Biopharm. 2007 Aug;67(1):67-75
17320362
Urol Res. 1995;23(1):1-10
7618229
BJU Int. 2007 Apr;99(4):881-6
17166242
J Appl Physiol (1985). 2005 Aug;99(2):479-87
15790688
IEEE Trans Ultrason Ferroelectr Freq Control. 2009 May;56(5):1006-17
19473917
Ulster Med J. 2005 May;74(1):66-7
16022139
Ultrasound Med Biol. 2008 Mar;34(3):435-45
17935872
Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):1085-99
1391430
Ultrasound Med Biol. 2000 Sep;26(7):1177-89
11053753
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1205-14
7849924
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1511-5
7849964
Scand J Urol Nephrol. 1999 Jun;33(3):162-70
10452291
AJR Am J Roentgenol. 2009 Jun;192(6):W300-5
19457793
Biochim Biophys Acta. 1985 Mar 29;839(1):1-8
3978117
Int J Urol. 2007 Jul;14(7):585-90; discussion 590
17645597
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1199-204
7849923
Adv Drug Deliv Rev. 1999 Apr 5;37(1-3):139-157
10837732
Physiol Rev. 1987 Oct;67(4):1249-95
3317458
Ultrasound Med Biol. 2008 Jul;34(7):1182-5
18295967
Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1043-54
7849908